Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
NMR in Biomedicine|September 4, 2019
Successful urinary discrimination between calcium oxalate kidney stone patients and healthy subjects using 1 H NMR spectroscopy: Suggestion of a possible link to protein contentSheila Shadbolt, Graham E Jackson, Allen L RodgersClinical Chemistry and Laboratory Medicine|November 19, 2002
Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-prone and stone-free population groupsDawn Webber, Allen L Rodgers, Edward D SturrockJournal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|January 15, 2004
Nucleation of calcium oxalate crystals on an imprinted polymer surface from pure aqueous solution and urineTimothy J Egan, Allen L Rodgers, Tewolde SieleJournal of Endourology|December 19, 2013
Variability in kidney stone incidence between black and white South Africans: AGT Pro11Leu polymorphism is not a factorTakalani Theka, Allen L Rodgers, Dawn Webber, et al.Urolithiasis|January 9, 2019
Correction to: Testing the dogma that total phospholipid fatty acid composition of blood plays a role in kidney stone pathogenesis, using a high-low risk human model: results from a pilot studyAllen L Rodgers, Dalielah Jappie-Mahomed, Paul J van JaarsveldUrolithiasis|June 18, 2017
Different effects of γ-linolenic acid (GLA) supplementation on plasma and red blood cell phospholipid fatty acid composition and calcium oxalate kidney stone risk factors in healthy subjects from two race groups with different risk profiles pose questions about the GLA-arachidonic acid-oxaluria metabolic pathway: pilot studyAllen L Rodgers, Dalielah Jappie-Mahomed, Paul J van JaarsveldUrolithiasis|July 1, 2018
Testing the dogma that total phospholipid fatty acid composition of blood plays a role in kidney stone pathogenesis, using a high-low risk human model: results from a pilot studyAllen L Rodgers, Dalielah Jappie-Mahomed, Paul J van JaarsveldUrolithiasis|January 9, 2019
Correction to: Different effects of γ-linolenic acid (GLA) supplementation on plasma and red blood cell phospholipid fatty acid composition and calcium oxalate kidney stone risk factors in healthy subjects from two race groups with different risk profiles pose questions about the GLA-arachidonic acid-oxaluria metabolic pathway: pilot studyAllen L Rodgers, Dalielah Jappie-Mahomed, Paul J van JaarsveldUrolithiasis|March 21, 2014
Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapyAllen L Rodgers, Dawn Webber, Ronica Ramsout, et al.Urological Research|January 21, 2011
Simulating calcium salt precipitation in the nephron using chemical speciationAllen L Rodgers, Shameez Allie-Hamdulay, Graham Jackson, et al.Pageof 4